In addition, we aimed to gain insights on the role of PIK3CA gain as a potential predictive marker of response to alpelisib in publicly available datasets of cancer cell lines23, patients derived xenograft (PDX)24 and patients with metastatic BC25–27. The gene discussed is PIK3CA; the disease is cancer.